| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $8.5M | -8.8% | +90.4% |
| Cost of Revenue | $3.3M | +11.4% | +241.6% |
| Gross Profit | $5.1M | -18.5% | +47.8% |
| R&D Expense | $236K | -59.5% | -67.2% |
| SG&A Expense | $3.5M | -8.6% | +90.3% |
| Pre-tax Income | $600K | -28.0% | +47.6% |
| Income Tax | $148K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $8.0M | -1.4% | — |
| Accounts Receivable | $869K | -32.2% | — |
| Current Assets | $15.0M | +1.3% | — |
| Total Assets | $22.8M | +2.6% | — |
| Current Liabilities | $5.2M | -2.8% | — |
| Total Liabilities | $5.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $2.7M | — | — |
| Investing Cash Flow | -$2.4M | — | — |
| Financing Cash Flow | -$150K | — | — |
| -26.9% |
| +383.0% |
| Net Income | $452K | -28.3% | +20.2% |
| EPS (Basic) | $0.01 | +0.0% | +0.0% |
| EPS (Diluted) | $0.01 | +0.0% | +0.0% |
| -2.7% |
| — |
| Stockholders' Equity | $17.2M | +4.5% | +148.4% |